Login / Signup

Evaluation of Tamsulosin 0.4 mg versus 0.8 mg in management of lower urinary tract symptoms due to benign prostatic enlargement.

Tarek OsmanHossam ElawadyKhaled FawazMohamed ShabayekMohammed Darweesh EssamDana OsmanKarim Omar ElSaeed
Published in: International urology and nephrology (2024)
M S 292/2020, SID: 373, date: 22/4/2020.
Keyphrases
  • benign prostatic hyperplasia
  • lower urinary tract symptoms
  • prostate cancer